Nature Communications (May 2019)
Publisher Correction: Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy
- Jennifer L. Caswell-Jin,
- Katherine McNamara,
- Johannes G. Reiter,
- Ruping Sun,
- Zheng Hu,
- Zhicheng Ma,
- Jie Ding,
- Carlos J. Suarez,
- Susanne Tilk,
- Akshara Raghavendra,
- Victoria Forte,
- Suet-Feung Chin,
- Helen Bardwell,
- Elena Provenzano,
- Carlos Caldas,
- Julie Lang,
- Robert West,
- Debu Tripathy,
- Michael F. Press,
- Christina Curtis
Affiliations
- Jennifer L. Caswell-Jin
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Katherine McNamara
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Johannes G. Reiter
- Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine
- Ruping Sun
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Zheng Hu
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Zhicheng Ma
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Jie Ding
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- Carlos J. Suarez
- Department of Pathology, Stanford University School of Medicine
- Susanne Tilk
- Department of Biology, Stanford University
- Akshara Raghavendra
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center
- Victoria Forte
- Maimonides Medical Center
- Suet-Feung Chin
- Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge
- Helen Bardwell
- Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge
- Elena Provenzano
- Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust
- Carlos Caldas
- Cancer Research UK Cambridge Institute, Department of Oncology, University of Cambridge
- Julie Lang
- Norris Comprehensive Cancer Center
- Robert West
- Department of Pathology, Stanford University School of Medicine
- Debu Tripathy
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center
- Michael F. Press
- Norris Comprehensive Cancer Center
- Christina Curtis
- Department of Medicine, Division of Oncology, Stanford University School of Medicine
- DOI
- https://doi.org/10.1038/s41467-019-10456-x
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 1 – 1
Abstract
The original version of this Article omitted from the Author Contributions statement that ‘R.S. and J.G.R contributed equally to this work.’ This has been corrected in both the PDF and HTML versions of the Article.
